Strategic Asia expansion Opportunity to leverage Bionik’s expanded Asia footprint via Pro-Med Technologies in Hong Kong to accelerate regional adoption of InMotion robots among hospitals, rehabilitation centers, and payer networks.

Clinical partnerships Existing collaborations with Duke Lifepoint Health and inpatient facilities suggest a track record of integrating InMotion robotics into stroke and neurological rehab pathways; target additional IRFs and hospital networks to scale utilization.

Home and wearables Development of home-based InMotion and ARKE exoskeleton products opens a channel for direct-to-consumer programs, tele-rehab services, and outpatient-to-home care contracts with payers seeking lower-cost, at-home therapy options.

Proof of impact InMotion robots provide objective motor assessments alongside therapy, enabling data-driven treatment outcomes; position as a value proposition for hospitals pursuing outcome-based reimbursement and clinical evidence.

Funding and scale Small company with prior capital raises and a strategic CEO leadership transition; potential for targeted investor-backed growth rounds or strategic partnerships to fund broader deployments and regional sales expansions.